Oncology: International Journal of Cancer Research and Treatment
2017, Vol.92, No. 5, May 2017
Dohou J., Mouret-Reynier M., Kwiatkowski F., Arbre M., Herviou P., Pouget M., Abrial C., Penault-Llorca F
Young breast cancer (BC) patients receiving chemotherapy are at risk of chemotherapy-induced menopause (CIM). We sought to define the incidence rate of premature menopause after chemotherapy and to retrospectively investigate factors related to the onset of menopause.
We identified BC patients who had received chemotherapy at the Cancer Center (Centre Jean-Perrin). We selected premenopausal women aged between 18 and 50 years at the moment of diagnosis who received chemotherapy between 1994 and 2012.